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Introduction
Acute pain after cardiothoracic surgery is common, resulting from intraoperative interventions including incisions, cannulations, tissue dissection, sternal wiring, and placement of chest tubes [1] [2] [3] [4] . Given the various factors that can trigger the pain response and the complexity of managing pain in the postoperative setting, this remains an ongoing challenge for health care providers.
Standard approaches to postoperative pain management include the use of opioid analgesics, nonopioid analgesics, local anesthetics, and epidural analgesia [5] . Opioid analgesic agents are used frequently to manage postoperative pain; however, adverse effects including drowsiness and respiratory depression can delay extubation and prolong intensive care unit (ICU) length of stay [6, 7] . Nonsteroidal anti-inflammatory drug (NSAIDs) use may be limited by the increased risk of renal dysfunction and bleeding in cardiac surgery patients [8, 9] . Safe insertion of an epidural catheter is also a challenge, as cardiac surgery patients routinely receive therapeutic anticoagulation during surgery. Furthermore, epidural analgesia is frequently associated with hypotension in the postoperative setting [5] . Proactive pain management with a multimodal strategy is recommended as the use of multiple agents can increase efficacy through V C 2017 American Academy of Pain Medicine. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com varying mechanisms while minimizing the adverse effects from high doses of single agents [10] .
Continuous infusion of local anesthetic at the surgical site with an elastomeric pump has been shown to improve postoperative pain control in a variety of surgical specialties [9, 11] . The use of elastomeric pumps in cardiothoracic surgery, filled with either ropivacaine or bupivacaine, has previously been associated with lower pain scores, decreased length of stay, and lower overall opioid consumption in several prospective studies [12] [13] [14] [15] . However, a single prospective study in cardiac surgery patients failed to show improvements in postoperative pain control with local administration of anesthetic [16] . Limitations to these previously published studies include small sample sizes, varying analgesics and protocols, and inconsistent duration of local anesthetic infusion.
As the current literature is conflicting, an opportunity exists to evaluate the role of local wound anesthesia in a real-world cardiac surgery setting. The purpose of this study was to assess the effectiveness of local anesthesia delivered via elastomeric pump to manage pain in patients undergoing cardiothoracic surgery.
Methods
This retrospective cohort study was performed at St. John Hospital and Medical Center in Detroit, Michigan, and St. John Macomb-Oakland Hospital in Warren, Michigan. The study was approved by the institutional review board. A list of patients who received cardiac surgery with median sternotomy between July 2011 and October 2013 was obtained from a surgical department database; data collection was conducted through review of the electronic medical record. Patients who received pain control by patient-controlled analgesia (PCA), epidural infusions, or peripheral nerve blocks were excluded. Patients with a history of substance abuse or sickle cell disease were also excluded. Renal function was assessed on postoperative day 1; renal dysfunction was defined as creatinine clearance less than 50 mL/min. Two hundred patients were evaluated in this study, 100 consecutive patients who received 0.5% bupivacaine delivered as a continuous infusion by elastomeric pump. The ON-Q Pain Relief System (I-Flow Corporation, Lake Forest, CA, USA) was utilized in the patients in the elastomeric pump group. Bilateral subpectoral infiltrating catheters were placed intraoperatively, parallel to the site of incision during chest closure. The catheters were connected to an elastomeric infusion pump with a 400 mL reservoir. The reservoir was filled with 0.5% bupivacaine, which was delivered at a fixed rate of 2 mL/h through each of the two infiltrating catheters (total 4 mL/h). The control group consisted of 100 patients who underwent cardiac surgery with median sternotomy who did not receive continuous infusion of bupivacaine via an elastomeric pump. During the postoperative period, all patients received pain management at the discretion of the surgical team. The elastomeric pump was maintained in place for 96 hours following surgery.
The primary efficacy end point was total postoperative opioid requirements for 96 hours following surgery, reported as morphine equivalents (mg) [4] . Secondary end points included postoperative pain scores on the visual analog scale (VAS), nonopioid analgesic requirements for 96 hours after surgery, and frequency of postoperative adverse events.
This study was designed to have 80% power to detect 35% difference in postoperative opioid use with an alpha error rate of 0.05. Continuous variables were reported as mean with standard deviation. Categorical variables were described using frequency distributions. Student's t test was utilized to find a difference in opioid use. The Mann-Whitney U test was utilized to compare median VAS scores. Chi-squared analysis was utilized to compare the incidence of adverse events. Linear regression was done to predict morphine usage in the two groups after adjusting for potentially confounding variables. All data were analyzed with SPSS v. 22.0 (IBM Corporation, Pittsburgh, PA, USA); a P value of 0.05 or less was considered to indicate statistical significance.
Results
Patient baseline characteristics were similar between the groups (Table 1) . Morbid obesity was more common in the elastomeric pump group (P ¼ 0.03), while more patients in the nonelastomeric pump group had a history of opioid utilization prior to surgery (P ¼ 0.01). Off-pump CABG was more frequently performed in the elastomeric pump group (P ¼ 0.01). The majority of patients received IV push morphine (87.5%) during the postoperative period; other opioids utilized include fentanyl (10%) and hydromorphone (6%).
No difference was noted in the primary outcome, opioid utilization for the first 96 hours postoperatively (Figure 1 ), based upon receipt of an elastomeric pump. Opioid consumption was highest within the first 24 hours after surgery in both groups, which tapered off as the postoperative period progressed. No difference between groups was noted in utilization of ketorolac (On-Q 34% vs 40%, P ¼ 0.38) or acetaminophen (On-Q 95% vs 91%, P ¼ 0.27). To account for differences between groups at baseline, variables with P values of less than 0.8 were entered into a linear regression model; the difference in postoperative opioid consumption remained statistically insignificant following this analysis (Table 2) .
Pain scores during the initial 96-hour postoperative period were similar between groups (Table 3 ). The use of antiemetic drugs, a surrogate for nausea and vomiting, was similar between groups (46% vs. 44%, P ¼ 0.78). Respiratory depression was more common in patients with an elastomeric pump (4% vs 0%), however, re-intubation occurred at a similar frequency in each group (5% vs 2%, P ¼ 0.25). No patients in the study had a documented hypersensitivity reaction or required naloxone for opioid reversal.
Comment
Inadequate pain management after cardiothoracic surgery is a continued issue in contemporary postoperative care. The most recent Society of Critical Care Medicine guidelines for the management of pain, agitation, and delirium specifically highlight this problem, issuing a statement pertaining to poor management of pain following cardiac surgery [4] . Poorly managed pain can lead to delayed wound healing, a prolonged ICU length of stay, and patient displeasure. One study that interviewed cardiac surgery patients who had been discharged from the ICU found that up to 77% of patients recalled experiencing moderate to severe pain during their ICU stay [17] . Given the various etiologies of pain following cardiac surgery, a multimodal pain management technique is recommended to optimize pain control. As an opportunity to improve pain management currently exists in this population, new and creative options need to be evaluated.
Continuous infusion of local anesthetic at the surgical site is gaining recognition as an alternative strategy for pain management. Dowling et al. evaluated the use of continuous infusion of ropivacaine in patients undergoing median sternotomy and found that the use of elastomeric pumps, in conjunction with traditional modalities for pain management, resulted in lower overall pain scores and shorter duration length of stay when compared with patients who received opioids and a placebo infusion [12] . White et al. performed a similar study and found that continuous infusion of 0.5% bupivacaine at the incision site led to lower overall pain scores, as compared with continuous infusion of normal saline [6] . Several other studies have reported similar results, noting possible reductions in hospital length of stay and opioid consumption [13] [14] [15] . An important limitation to note is that the majority of these studies were funded 
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by I-Flow Corporation, the manufacturer of the ON-Q Pain Relief System. Other limitations to these studies include small sample sizes, varying analgesic protocols, and inconsistent duration of local anesthetic infusion.
Conflicting results have been reported by other studies conducted in a cardiothoracic surgery population. Gebhardt et al. compared the use of continuous infusion of ropivacaine by elastomeric pump and intravenous opioids with thoracic epidural catheters placed by an anesthesiologist in patients undergoing thoracotomy. Even though patients in the elastomeric pump group had shorter overall length of stay, they reported higher overall pain scores compared with those in the thoracic epidural group [5] . Magnano et al. evaluated the use of continuous infusion of bupivacaine for 36 hours following cardiac surgery, noting no difference in overall pain scores and longer time to extubation in patients who received continuous infusion of local anesthetic [16] .
Limitations to these studies, once again, include small sample sizes, differing surgical practices, and varying analgesic regimens utilized.
Given the disparity in literature with regard to the effectiveness of elastomeric pumps in cardiothoracic surgery, we decided to perform a retrospective evaluation of patients at our institution. This study found no difference in postoperative opioid consumption or pain scores with utilization of an elastomeric pain pump. Even after accounting for confounding variables (morbid obesity, opioid use prior to admission, surgery type, ICU LOS, duration of mechanical ventilation), postoperative opioid consumption remained similar between both groups. In contrast to previous literature, use of an elastomeric pump was associated with a longer ICU length of stay in our study. It is important to recognize that ICU length of stay is impacted by many factors, including patient comorbid conditions and institutional policies governing ICU discharge [18] . Patients in the elastomeric pump group had significantly more patients with morbid obesity, which may have contributed to a longer ICU length of stay. Furthermore, the majority of patients in our study received morphine. A higher incidence of renal dysfunction was present in the elastomeric pump group, which could have led to morphine-6-glucuronide accumulation and prolongation of ICU stay.
This study does have noted limitations. First, the retrospective design may have resulted in selection bias. Second, inconsistent electronic charting of pain scores and duration of local anesthetic infusion could have influenced the overall reported opioid consumption and median pain scores. In spite of these limitations, it is important to note that this study was adequately powered to detect a difference in overall opioid consumption and pain scores. Furthermore, this study is the largest study evaluating the use of the elastomeric pain pump in cardiothoracic surgery patients conducted to date.
Given the questionable efficacy of elastomeric pumps in cardiothoracic surgery, one has to consider the financial implications of utilizing this modality of pain management. The cost of utilizing these pumps can range upwards of $300, without providing any additional benefit as compared with other available options. As the cost of providing health care continues to rise, health systems are under immense pressure to practice evidencebased medicine and streamline services offered to their patients. Given the current trends in health care reimbursement and spending, the use of these pumps in a cardiac surgery patient population needs to be revisited.
In conclusion, we report that the use of elastomeric pumps in patients undergoing cardiothoracic surgery is not as beneficial in reducing postoperative opioid consumption and postoperative pain as previously reported. Table 3 Pain score assessment 
